Medicinova Inc (NASDAQ: MNOV)
$2.1500
+0.6200 ( +40.52% ) 714.0K
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
Market Data
Open
$2.1500
Previous close
$1.5300
Volume
714.0K
Market cap
$100.55M
Day range
$1.5240 - $2.1500
52 week range
$1.1200 - $2.1600
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 45 | Aug 08, 2024 |
| 4 | Insider transactions | 1 | Jun 12, 2024 |
| 4 | Insider transactions | 1 | Jun 12, 2024 |
| 4 | Insider transactions | 1 | Jun 12, 2024 |
| 8-k | 8K-related | 11 | Jun 12, 2024 |
| 10-q | Quarterly Reports | 44 | May 09, 2024 |
| ars | Annual reports | 1 | Apr 26, 2024 |
| def | Proxies and info statements | 8 | Apr 26, 2024 |
| 8-k | 8K-related | 13 | Apr 01, 2024 |
| 10-k | Annual reports | 65 | Feb 15, 2024 |